Riskpilot← Back to searchSign inGet full accessINMED AS
ASActiveOrg 922179956Nedre Vikan 2C, 7240 HitraOther human health activities n.e.c. · NACE 8699Est. 20191 employees
Revenue 2024
NOK 2,8M
+8% vs 2023
EBITDA margin
28.4%
+7% vs 2023
Equity ratio
37.6%
Financial strength
Net profit 2024
NOK 387K
+24% vs 2023
| Revenue | NOK 2,8M | +8% |
| EBITDA | NOK 803K | +7% |
| Net profit | NOK 387K | +24% |
| Total assets | NOK 4,3M | -5% |
| Equity | NOK 1,6M | +21% |
| Employees | 1 | — |
Legal name
INMED AS
Org number
922179956
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
7. februar 2019
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Medisinske tjenester. Kurs og foredragstjenester.
Address
Nedre Vikan 2C, 7240 Hitra
Phone
+4790190189
Email
post@inmed.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 782 | 2 224 | 2 450 | 2 609 | 2 824 |
| Staff expenses | −666 | −718 | −762 | −932 | −1 043 |
| EBITDA | 507 | 742 | 1 002 | 750 | 803 |
| Depreciation & amort. | −175 | −200 | −216 | −196 | −175 |
| EBIT | 332 | 542 | 786 | 554 | 627 |
| Net financials | −149 | −102 | −120 | −155 | −125 |
| Profit before tax | 183 | 440 | 666 | 400 | 503 |
| Tax | 40 | 98 | 148 | 89 | 116 |
| Net profit | 143 | 342 | 518 | 311 | 387 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 721 | 4 786 | 4 842 | 4 565 | 4 337 |
| Equity | 174 | 516 | 1 033 | 1 345 | 1 631 |
| Long-term debt | 4 061 | 3 707 | 3 270 | 2 932 | 2 401 |
| Short-term debt | 487 | 563 | 539 | 289 | 306 |
| Total debt | 4 548 | 4 270 | 3 809 | 3 220 | 2 706 |
EBITDA margin
28.4%
This company
15.8%
Market median
+80% vs market
20202024
Equity ratio
37.6%
This company
38.2%
Market median
+2% vs market
20202024
Return on equity
23.7%
This company
18.4%
Market median
+29% vs market
20202024
Net profit margin
13.7%
This company
8.1%
Market median
+69% vs market
20202024
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20202024
Debt / equity
1.66×
This company
0.62×
Market median
-168% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Board of Directors | 2019 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of INMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Knut Are Elvemo | Board of Directors | 0 companies |
| Jonas Nilsberg Refsnæs | Board of Directors | 0 companies |
| Anne Berit Nilsberg | Chairman | 0 companies |
| Svein Roar Elvemo | Board of Directors | 0 companies |
| Kristina Kaald | Board of Directors | 0 companies |